Skip to content
RDL Network logo
Lentiviral Hematopoietic Stem and Progenitor Cell Gene Therapy for Metachromatic Leukodystrophy (MLD): Clinical Outcomes from 38 Patients — Mirko M. Essing (2021) | RDL Network